Initial studies of families with early-onset, autosomal dominant AD led to the discovery of amyloid precursor protein (APP)1–3 and presenilin-1/2 (PSEN1/2)4,5, and genome sequencing studies in large population-based AD cohorts have begun to identify other rare, non-synonymous risk variants6,7. Here, APP is linked to Alzheimer disease.